{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:05:07Z","timestamp":1791230707163,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.biomaterials.2010.11.079","type":"journal-article","created":{"date-parts":[[2010,12,25]],"date-time":"2010-12-25T05:03:41Z","timestamp":1293253421000},"page":"2399-2406","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":101,"title":["Targeted delivery of chlorotoxin-modified DNA-loaded nanoparticles to glioma via intravenous administration"],"prefix":"10.1016","volume":"32","author":[{"given":"Rongqin","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weilun","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.biomaterials.2010.11.079_bib1","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/neuonc\/4.4.278","article-title":"Epidemiology of primary brain tumors: current concepts and review of the literature","volume":"4","author":"Wrensch","year":"2002","journal-title":"Neuro Oncol"},{"issue":"9354","key":"10.1016\/j.biomaterials.2010.11.079_bib2","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0140-6736(03)12328-8","article-title":"Primary brain tumours in adults","volume":"361","author":"Behin","year":"2003","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.biomaterials.2010.11.079_bib3","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.3171\/foc.2006.20.4.E1","article-title":"Trends in brain cancer incidence and survival in the United States: surveillance, epidemiology, and end results program, 1973 to 2001","volume":"20","author":"Deorah","year":"2006","journal-title":"Neurosurg Focus"},{"issue":"7","key":"10.1016\/j.biomaterials.2010.11.079_bib4","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S1474-4422(05)70118-6","article-title":"Surgery for malignant gliomas: mechanistic reasoning and slippery statistics","volume":"4","author":"Mitchell","year":"2005","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1016\/j.biomaterials.2010.11.079_bib5","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00401-007-0293-7","article-title":"Diffuse glioma growth: a guerilla war","volume":"114","author":"Claes","year":"2007","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.1016\/j.biomaterials.2010.11.079_bib6","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.ijrobp.2005.08.013","article-title":"[F-18]-fluorodeoxyglucose positron emission tomography for targeting radiation dose escalation for patients with glioblastoma multiforme: clinical outcomes and patterns of failure","volume":"64","author":"Douglas","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"10.1016\/j.biomaterials.2010.11.079_bib7","first-page":"894","article-title":"Radiotherapy and radiosensitizers in the treatment of glioblastoma multiforme","volume":"5","author":"Chang","year":"2007","journal-title":"Clin Adv Hematol Oncol"},{"issue":"6","key":"10.1016\/j.biomaterials.2010.11.079_bib8","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/sj.gt.3302238","article-title":"Gene therapy progress and prospects: cancer gene therapy using tumour suppressor genes","volume":"11","author":"McNeish","year":"2004","journal-title":"Gene Ther"},{"issue":"22","key":"10.1016\/j.biomaterials.2010.11.079_bib9","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/sj.gt.3303033","article-title":"Progress and prospects: gene therapy clinical trials (part 2)","volume":"14","author":"Alton","year":"2007","journal-title":"Gene Ther"},{"issue":"2","key":"10.1016\/j.biomaterials.2010.11.079_bib10","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.biomaterials.2007.09.024","article-title":"The use of lactoferrin as a ligand for targeting the polyamidoamine-based gene delivery system to the brain","volume":"29","author":"Huang","year":"2008","journal-title":"Biomaterials"},{"issue":"36","key":"10.1016\/j.biomaterials.2010.11.079_bib11","doi-asserted-by":"crossref","first-page":"6976","DOI":"10.1016\/j.biomaterials.2009.08.049","article-title":"Gene delivery targeted to the brain using an angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer","volume":"30","author":"Ke","year":"2009","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.biomaterials.2010.11.079_bib12","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1023\/A:1006760632766","article-title":"Expression of matrix metalloproteinases and their inhibitors in human brain tumors","volume":"17","author":"Kachra","year":"1999","journal-title":"Clin Exp Metastasis"},{"issue":"6","key":"10.1016\/j.biomaterials.2010.11.079_bib13","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1074\/jbc.M205662200","article-title":"Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2","volume":"278","author":"Deshane","year":"2003","journal-title":"J\u00a0Biol Chem"},{"issue":"2","key":"10.1016\/j.biomaterials.2010.11.079_bib14","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/glia.10083","article-title":"Chlorotoxin, a scorpion-derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin","volume":"39","author":"Lyons","year":"2002","journal-title":"Glia"},{"issue":"3","key":"10.1016\/j.biomaterials.2010.11.079_bib15","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/bip.10257","article-title":"Therapeutic cancer targeting peptides","volume":"66","author":"Aina","year":"2002","journal-title":"Biopolymers"},{"issue":"2","key":"10.1016\/j.biomaterials.2010.11.079_bib16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11060-004-0890-4","article-title":"Radiation dosimetry of 131I-chlorotoxin for targeted radiotherapy in glioma-bearing mice","volume":"71","author":"Shen","year":"2005","journal-title":"J\u00a0Neurooncol"},{"issue":"5327","key":"10.1016\/j.biomaterials.2010.11.079_bib17","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1126\/science.277.5327.815","article-title":"An antagonist decoy receptor and a death domain-containing receptor for TRAIL","volume":"277","author":"Pan","year":"1997","journal-title":"Science"},{"issue":"14","key":"10.1016\/j.biomaterials.2010.11.079_bib18","doi-asserted-by":"crossref","first-page":"6882","DOI":"10.1158\/0008-5472.CAN-06-3948","article-title":"Tumor paint: a chlorotoxin: cy5.5 bioconjugate for intraoperative visualization of cancer foci","volume":"67","author":"Veiseh","year":"2007","journal-title":"Cancer Res"},{"issue":"12","key":"10.1016\/j.biomaterials.2010.11.079_bib19","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1007\/s11095-005-8330-5","article-title":"Tat-conjugated PAMAM dendrimers as delivery agents for antisense and siRNA oligonucleotides","volume":"22","author":"Kang","year":"2005","journal-title":"Pharm Res"},{"issue":"1\u20133","key":"10.1016\/j.biomaterials.2010.11.079_bib20","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0168-3659(01)00513-2","article-title":"Optimization of factors influencing the transfection efficiency of folate-PEG-folate-graft-polyethylenimine","volume":"79","author":"Benns","year":"2002","journal-title":"J\u00a0Control Release"},{"issue":"7\u20138 Suppl.","key":"10.1016\/j.biomaterials.2010.11.079_bib21","doi-asserted-by":"crossref","first-page":"S328","DOI":"10.1016\/j.apradiso.2009.03.030","article-title":"Boron neutron capture therapy of EGFR or EGFRvIII positive gliomas using either boronated monoclonal antibodies or epidermal growth factor as molecular targeting agents","volume":"67","author":"Yang","year":"2009","journal-title":"Appl Radiat Isot"},{"issue":"10","key":"10.1016\/j.biomaterials.2010.11.079_bib22","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1021\/bc900228m","article-title":"PAMAM\u2013RGD conjugates enhance siRNA delivery through a multicellular spheroid model of malignant glioma","volume":"20","author":"Waite","year":"2009","journal-title":"Bioconjugate Chem"},{"issue":"4","key":"10.1016\/j.biomaterials.2010.11.079_bib23","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1089\/hum.2009.087","article-title":"Tat\u2013BMPs\u2013PAMAM conjugates enhance therapeutic effect of small interference RNA on U251 glioma cells in vitro and in vivo","volume":"21","author":"Han","year":"2010","journal-title":"Hum Gene Ther"},{"issue":"3","key":"10.1016\/j.biomaterials.2010.11.079_bib24","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jconrel.2006.10.020","article-title":"Comparison of the endocytic properties of linear and branched PEIs, and cationic PAMAM dendrimers in B16f10 melanoma cells","volume":"117","author":"Seib","year":"2007","journal-title":"J\u00a0Control Release"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961210015346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961210015346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T15:25:19Z","timestamp":1758900319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961210015346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0142961210015346"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2010.11.079","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted delivery of chlorotoxin-modified DNA-loaded nanoparticles to glioma via intravenous administration","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2010.11.079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}